You are here

Article Text

Article menu
Download PDFPDF
Case Reports: Rare disease
Mycobacterium ulcerans lung infection in an immunocompetent patient
  1. Shadi Chamseddine1,
  2. Joya-Rita Hindy1,
  3. Sara F Haddad2 and
  4. Souha S Kanj1
  1. 1American University of Beirut Medical Center, Beirut, Lebanon
  2. 2Infectious Diseases, American University of Beirut Medical Center, Beirut, Lebanon
  1. Correspondence to Souha S Kanj; sk11{at}aub.edu.lb

Abstract

Mycobacterium ulcerans has been implicated in cutaneous manifestations in humans, causing persistent wounds called Buruli ulcer. However, it has not been associated with pulmonary infections in humans to date. Herein, we report a case of an immunocompetent adult man with no underlying medical problems presenting with dyspnoea and generalised malaise and diagnosed with M. ulcerans lung infection. The patient was prescribed clarithromycin 500 mg two times per day, rifampin 300 mg two tablets daily and moxifloxacin 400 mg daily for 6 months, with complete resolution of his symptoms.

  • TB and other respiratory infections
  • Infectious diseases

https://doi.org/10.1136/bcr-2022-250547

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Twitter @Haddad_Sara7

    • Correction notice Since this paper was first published, the author order has been modified.

    • Contributors SSK: conceptualisation, writing - original draft, writing - review and editing, supervision, project administration. SH, JH, SC: investigation, writing - original draft, writing - review and editing.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; externally peer reviewed.